PTK2 and cancer: It has been reported that activation of integrin signaling molecules including FAK and ERK is known to promote anoikis resistance, migration, invasion, and metastasis of cancer cells13–16, and both FAK and ERK are thus suggested as therapeutic targets17,18 while side effects disturbing normal cell functions have also been reported19.